Offer - Urjas Oil for just ₹ 1 X
Sefozon Sbt is a prescription drug, available for use as Injection. The alternative uses of Sefozon Sbt have also been explained below.
The optimal dosage of Sefozon Sbt is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The most common side effects of Sefozon Sbt are Diarrhoea, Rash, Allergic reaction. Some other side effects of Sefozon Sbt have been listed ahead. Such side effects of Sefozon Sbt normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Sefozon Sbt is Safe for pregnant women and Mild for women who are breastfeeding. In addition, Sefozon Sbt's effects on the liver, heart and kidney are discussed below in the Sefozon Sbt related warnings section.
Sefozon Sbt is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy are examples of such conditions.
Besides this, Sefozon Sbt may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Sefozon Sbt is considered not safe while driving, and is not addictive.
Sefozon Sbt is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Sefozon Sbt safe for pregnant women?
Pregnant women can take Sefozon Sbt without worrying about any side effects.
Is the use of Sefozon Sbt safe during breastfeeding?
Breastfeeding women can take Sefozon Sbt as it bears very minor side effects for them.
What is the effect of Sefozon Sbt on the Kidneys?
No research work has been carried out till date on effects of Sefozon Sbt on kidney. So it is not known whether taking Sefozon Sbt will cause side effects on kidney or not.
What is the effect of Sefozon Sbt on the Liver?
The liver can be affected by Sefozon Sbt. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Sefozon Sbt only after medical advice.
What is the effect of Sefozon Sbt on the Heart?
Side effects of Sefozon Sbt on heart are unknown because research on this has not been conducted yet.
Sefozon Sbt should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Sefozon Sbt unless your doctor advises you to do so -
Is this Sefozon Sbt habit forming or addictive?
No, there is no any evidence that Sefozon Sbt is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Sefozon Sbt. So it is best to avoid driving.
Is it safe?
Yes, but take Sefozon Sbt only as per medical advice.
Is it able to treat mental disorders?
No, the use of Sefozon Sbt in mental disorders is not effective.
Interaction between Food and Sefozon Sbt
It is safe to take Sefozon Sbt with food.
Interaction between Alcohol and Sefozon Sbt
It is difficult to say anything about the effect of Sefozon Sbt and alcohol. No research has been done on this yet.
Occasionally Sefozon Sbt can cause a drug to induce hemolytic anemia (abnormal Red blood cell breakdown). However, if your blood reports are showing abnormal hemolytic anemia after taking this drug please discuss with your doctor.
Sefozon Sbt can be safely taken as prescribed by your doctor. Do not discontinue the medicine suddenly or take it longer than prescribed duration.
No, you can not buy Sefozon Sbt over-the-counter. It is a prescription drug, without prescription of a healthcare practitioner, you can not buy directly from the pharmacy. It is for our own safety, please remember taking antibiotics without doctors advice can lead to unwanted side effects.
Do not self-administer Sefozon Sbt. It comes in the form of injection and preferably taken 1 - 2 times in a day (Intravenously or Intramuscularly). Take this medicine in the required quantity and duration as prescribed by your doctor. Discontinuing the a in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 14 days course even after getting symptomatic relief. In case you feel any discomfort such as breathing difficulties and skin reactions while taking this medicine please inform your doctor immediately.
Rarely Sefozon Sbt can cause neurotoxicity. It is a reversible side effect of this drug, the symptoms caused due to drug-induced neurotoxicity often disappear after this drug is stopped. However, if you experience convulsions, agitation, weakness and severe nausea do not hesitate to inform your doctor without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162